Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Encapsulation Systems, Inc. (ESI) is a medical technology company specializing in high-performance UV curing systems, medical waste management, and advanced drug delivery platforms. The company is widely recognized for its Bio-Safe System, a patented technology for the on-site treatment and encapsulation of medical waste, and its UV curing equipment used extensively in the assembly of medical devices such as catheters and hearing aids. Additionally, ESI developed the Microencapsulated Drug Delivery System (MEDDS) in collaboration with NASA, a platform designed to create uniform microcapsules for the targeted delivery of chemotherapy and other pharmaceuticals. Based in Pennsylvania, ESI serves a global clientele across the healthcare, pharmaceutical, and electronics industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Encapsulation Systems.